主动脉瘤市场规模、份额、成长分析、按类型、按治疗方法、按产品、按最终用途、按地区 - 行业预测，2025-2032

2023 年全球主动脉瘤 (AA) 市场规模价值为 41.2 亿美元，预计将从 2024 年的 45.2 亿美元增长到 2032 年的 95.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.8%。

市场动态受到人口老化加剧、动脉硬化（尤其是心血管疾病）盛行率上升以及不健康的生活方式的影响。光是在美国，老年人口预计将从目前的5,400万人增加到2040年的8,080万人，到2060年将增加至9,470万人，这将扩大需要主动脉瘤治疗的患者数量。有关医疗保险报销的优惠规定以及对血管支架主动脉修復（EVAR）等微创手术的需求激增，进一步推动了市场成长。这些手术具有失血量减少、切口更小、恢復更快、疗效更佳等优点，因此越来越有吸引力。此外，吸烟仍然是一个重要的危险因素，尤其是在老年人中，影响主动脉瘤的进展和手术结果。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术进步
• 监管格局
• 专利分析

主动脉瘤市场规模（按类型）

• 市场概况
• 胸主动脉瘤（TAA）
• 腹部主动脉血管瘤(AAA)

主动脉瘤市场规模：依治疗方法

• 市场概况
• 开放性手术(OSR)
• 血管支架置换术 (EVAR)

主动脉瘤市场规模：依产品

• 市场概况
• 血管支架
• 导管
• 其他的

主动脉瘤市场规模：依最终用途

• 市场概况
• 医院
• 门诊手术中心（ASC）
• 其他的

主动脉瘤市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic（USA）
• WL Gore & Associates, Inc.（USA）
• Cook Medical（USA）
• Terumo Corporation（Japan）
• Cardinal Health（USA）
• Endologix, LLC（USA）
• Lombard Medical（UK）
• CryoLife, Inc.（USA）
• MicroPort Scientific Corporation（China）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Becton, Dickinson and Company（USA）
• Braun Melsungen AG（Germany）
• Getinge AB（Sweden）
• Merit Medical Systems, Inc.（USA）
• Terumo Aortic（UK）
• Biotronik SE & Co. KG（Germany）
• Medtronic Vascular, Inc.（USA）

结论和建议

Global Aortic Aneurysm Market size was valued at USD 4.12 billion in 2023 and is poised to grow from USD 4.52 billion in 2024 to USD 9.56 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).

Market dynamics are significantly influenced by the growing aging population and the rising prevalence of atherosclerosis, particularly with an increasing incidence of cardiovascular diseases and unhealthy lifestyle choices. In the U.S. alone, the elderly demographic is expected to rise from 54 million today to 80.8 million by 2040 and 94.7 million by 2060, expanding the patient base for aortic aneurysm (AA) repairs. Favorable health reimbursement regulations and a surge in demand for minimally invasive procedures, such as Endovascular Aneurysm Repair (EVAR), further bolster market growth. These procedures offer advantages such as reduced blood loss, smaller incisions, quicker recovery, and improved outcomes, making them increasingly attractive. Additionally, smoking remains a significant risk factor, especially in older adults, affecting AA progression and surgical outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Aneurysm Market Segments Analysis

Global Aortic Aneurysm Market is segmented by Type, Treatment, Product, End-Use and region. Based on Type, the market is segmented into Thoracic Aortic Aneurysm (TAA) and Abdominal Aortic Aneurysm (AAA). Based on Treatment, the market is segmented into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR). Based on Product, the market is segmented into Stent Grafts, Catheters and Others. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgery Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aortic Aneurysm Market

The Global Aortic Aneurysm market is primarily driven by the escalating number of aortic aneurysm cases, especially among the elderly demographic. This rise can be attributed to various risk factors, including hypertension, smoking, and atherosclerosis, which collectively elevate the occurrence of these conditions. As the prevalence of aortic aneurysms continues to grow, there is an urgent demand for advanced diagnostic tools and effective treatment options to manage and address these life-threatening issues. Consequently, the increasing awareness and need for improved healthcare solutions in this area are significantly propelling the market forward.

Restraints in the Global Aortic Aneurysm Market

One of the primary challenges facing the global aortic aneurysm market is the prevailing lack of awareness regarding the condition among both the general public and healthcare professionals. This widespread unawareness can lead to underdiagnosis, which in turn results in delayed treatment and, ultimately, unfavorable patient outcomes. Such issues not only compromise the health of individuals affected by aortic aneurysms but also significantly impede the overall growth of the market. Addressing this knowledge gap is essential for improving diagnosis rates and treatment efficacy, thereby fostering a more robust market environment.

Market Trends of the Global Aortic Aneurysm Market

The Global Aortic Aneurysm market is witnessing significant growth, driven by advancements in minimally invasive surgical techniques, increasing awareness of vascular diseases, and a rising geriatric population susceptible to aortic aneurysms. The development and adoption of innovative medical devices, such as endovascular stent grafts, along with improvements in diagnostic imaging technologies, are propelling market expansion. Additionally, an increasing focus on research and development activities to enhance patient outcomes is contributing to market dynamics. This trend is further supported by the growing prevalence of risk factors such as hypertension and smoking, underscoring the urgency for effective treatment options in the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Patent Analysis

Global Aortic Aneurysm Market Size by Type & CAGR (2025-2032)

• Market Overview
• Thoracic Aortic Aneurysm (TAA)
• Abdominal Aortic Aneurysm (AAA)

Global Aortic Aneurysm Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Open Surgical Repair (OSR)
• Endovascular Aneurysm Repair (EVAR)

Global Aortic Aneurysm Market Size by Product & CAGR (2025-2032)

• Market Overview
• Stent Grafts
• Catheters
• Others

Global Aortic Aneurysm Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Others

Global Aortic Aneurysm Market Size & CAGR (2025-2032)

• North America (Type, Treatment, Product, End-Use)
  • US
  • Canada
• Europe (Type, Treatment, Product, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Product, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Product, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Product, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W.L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lombard Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Aortic (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations